Myriad is an Utah-based healthcare company that discovers and commercializes molecular diagnostic tests and equipments for inherited diseases...
Read moreMyriad is an Utah-based healthcare company that discovers and commercializes molecular diagnostic tests and equipments for inherited diseases...
Read more1991
PublicIndependent CompanyNASDAQMYGN
Annual Revenue
$661.4M
Myriad's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 993.4M. Over the last four quarters, Myriad's revenue has decreased by 2.7%. Specifically, in Q3 2022's revenue was $156.4M; in Q2 2022, it was $179.3M; in Q1 2022, it was $164.9M; in Q4 2021, Myriad's revenue was $160.8M.